TXT
70
-2
EXPE
54
-2
AIZ
61
5
L
67
3
TRV
42
5
SYY
31
-4
FFIV
52
3
LYB
44
3
QRVO
59
6
PM
41
2
ACN
22
6
GE
55
-5
MAC
53
2
TSN
58
2
DOW
62
2
HSY
53
3
PNC
59
3
NTAP
46
3
MO
45
-2
YUM
58
2
TXT
70
-2
EXPE
54
-2
AIZ
61
5
L
67
3
TRV
42
5
SYY
31
-4
FFIV
52
3
LYB
44
3
QRVO
59
6
PM
41
2
ACN
22
6
GE
55
-5
MAC
53
2
TSN
58
2
DOW
62
2
HSY
53
3
PNC
59
3
NTAP
46
3
MO
45
-2
YUM
58
2
Financhill
Back

Black Diamond Therapeutics, Inc. 10K Form

Buy
67

BDTX
Black Diamond Therapeutics, Inc.

Last Price:
$2.40
Seasonality Move:
-5.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDTX News And Ratings

See the #1 stock for the next 7 days that we like better than BDTX

BDTX Financial Statistics

Sales & Book Value

Annual Sales: $70M
Cash Flow: $-6.8M
Price / Cash Flow: 4.61
Annual Sales: $1.96
Price / Book: 1.22

Profitability

EPS (TTM): 0.38040
Net Income (TTM): $22.4M
Gross Margin: $69.7M
Return on Equity: 18.77%
Return on Assets: 14.6%

Black Diamond Therapeutics, Inc. Earnings Forecast

Key Black Diamond Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 5 years for BDTX is 99.54%.
  • The Selling, General & Administrative Expenses for BDTX have been equal to 23.67% of Gross Profit Margin.
  • The Research & Development expenses have been 47.48% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of BDTX is 31.95% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Black Diamond Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BDTX
CUSIP: 09203E
Website: blackdiamondtherapeutics.com

Debt

Debt-to-Equity Ratio: 0.17
Current Ratio: 8.42
Quick Ratio: 8.18

Price-to-Earnings

Trailing P/E Ratio: 6.15
Forward P/E Ratio: 0

BDTX Technical Analysis vs Fundamental Analysis

Buy
67
Black Diamond Therapeutics, Inc. (BDTX) is a Buy

Is Black Diamond Therapeutics, Inc. a Buy or a Sell?